Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme

Bioorganic Chemistry - Tập 83 - Trang 47-54 - 2019
Lamia W. Mohamed1, Mohamed A. Shaaban1, Ashraf F. Zaher1, Shimaa M. Alhamaky2, Ayman M. Elsahar3
1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
2Pharmaceutical Chemistry Department, Faculty of Pharmacy, Menofia University, Menofia, Egypt
3Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Tài liệu tham khảo

Hilário, 2006, Non-steroidal anti-inflammatory drugs:cyclooxygenase 2 inhibitors, J. de pediatria, 82, 206, 10.2223/JPED.1560 Dube, 2014, Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study, Chem. Biol. Drug Des., 84, 409, 10.1111/cbdd.12324 Brune, 2004, Scand. Selective cyclooxygenase-2 inhibitors: similarities and differences, J. Rheumatol., 33,1 Mcgettigan, 2000, Current problems with non-specific COX inhibitors, Curr. Pharm. Des., 6, 1693, 10.2174/1381612003398690 Mohamed, 2017, Selective COX-2 inhibitors and risk of thromboembolic events –regulatory aspects, Bioorg. Chem., 72, 308, 10.1016/j.bioorg.2017.04.012 Alam, 2015, A review on pyrazole chemical entity and biological activity, Int. J. Pharm. Sci. Res, 6, 1433 Goldenberg, 1999, Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis, Clin. Ther., 21, 1497, 10.1016/S0149-2918(00)80005-3 Szabó, 2007, New celecoxib derivatives as anti-inflammatory agents, J. Med. Chem., 51, 142, 10.1021/jm070821f Tewari, 2014, Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents, Bio org. Chem., 56, 8 Hamdy, 2009, New pyridone, thioxopyridine, pyrazolopyridine and pyridine derivatives that modulate inflammatory mediators in stimulated RAW 264.7 murine macrophage, Eur. J. Med. Chem., 44, 4547, 10.1016/j.ejmech.2009.06.023 El-Assiery, 2004, Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine, pyrazolopyridine and pyranopyrazole derivatives, Acta. Pharm., 54, 143 Penning, 1997, Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib), J. Med. Chem., 40, 1347, 10.1021/jm960803q Michaux, 2004, Structural approach for COX-2 inhibition, Mini-Rev. Med. Chem., 4, 603, 10.2174/1389557043403756 Weissberger, 1943, Investigation of pyrazole compounds. 111’. The condensation of a-carbethoxyacetothioacetanilide with hydrazines, J. Am. Chem. Soc., 65, 732, 10.1021/ja01244a059 Summers, 1973, preparation of 3-methyl-4-(3'-pyridylhydrazon0)isoxazol-5-one and related compounds, Aust. J. Chem., 26, 2723, 10.1071/CH9732723 Rizk, 2011, Synthesis of some novel heterocyclic dyes derived from pyrazole derivatives, Arab. J. Chem., 4, 37, 10.1016/j.arabjc.2010.06.012 Thakare, 2012, Synthesis, characterization of some new 3, 5-dimethyl azopyrazoles and its derivatives, J. Chem. Pharm. Res., 4, 3329 Sivakumar, 2012, synthesis, characterization, in-vitro anti-oxidant and cytotoxic activity of n-mannich bases of 5-amino-4-[2-(6-bromo-1, 3-benzo thiazol-2-yl) hydrazinylidene]-2, 4-dihydro-3h-pyrazol-3-one, Int. J. Res. Pharm. Chem., 2, 327 Patra, 2014, synthesis and antibacterial activity screening of some novel pyrazole derivatives, Int. J. Pharm. Sci., 6, 801 Graham, 1949, Investigation of pyrazole compounds. VIII.' synthesis and acylation of pyrazolones derived from hydrazine and methylhydrazine, J. Am. Chem. Soc., 71, 983, 10.1021/ja01171a061 Shaaban, 2009, Synthesis of some isoxazolo [1, 4] diazepines, pyrazolo [1, 5] benzoxazepines and pyrazolo [1, 5] benzodiazepines related to CNS acting drugs, Bull. Fac. Pharm. Cairo Univ., 47, 35 Winter, 1962, Carrageenin-induced edema in hind paw of the ‘Rat as an assay for antiinflammatory drug, Exp. Biol. Med., 111, 544, 10.3181/00379727-111-27849